The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation

The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation

Abstract Background This study aimed to analyze associations between genetic variants and plasma concentrations along with clinical outcomes in dabigatran in patients with non-valvular atrial fibrillation (NVAF). Methods We conducted a prospective study and enrolled NVAF patients treated with dabiga...

Full description

Bibliographic Details
Main Authors: Zhu Zhu, Chenyue Qian, Cunjing Su, Hong Tao, Jiaojiao Mao, Zhening Guo, Xinyi Zhu, Jie Pan
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cardiovascular Disorders
Subjects:
Dabigatran
ABCB1
CES1
Single nucleotide polymorphisms
Online Access:https://doi.org/10.1186/s12872-022-02910-4

Internet

https://doi.org/10.1186/s12872-022-02910-4

Similar Items